Archives

by in
Entry Author Date Location
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study 05/15/13 San Francisco
Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyclics 05/06/13 New York
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Seattle Genetics Sees Updated Side Effect Warning in Drug Label 01/13/12 Seattle
Seattle Genetics Sees Case of PML, Causing Market Twitch 12/01/11 Seattle
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
Calistoga Rolls Out More Evidence For Blood Cancer Drug, Sizes Up Pivotal Trial 12/05/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch 11/18/10 Seattle
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared 11/17/10 San Francisco
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Biogen, Genentech Revamp Alliance 10/21/10 San Francisco
Calistoga Starts Mid-Stage Trial 10/19/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Novartis Test Drives Biotech Startup Adimab’s Drug Discovery Engine 07/09/10 Boston
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Calistoga Pharmaceuticals Builds Stronger Case for Blood Cancer Drug 06/07/10 Seattle
Trubion Wins Genentech, Biogen Patent Case 06/03/10 Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug 05/26/10 Seattle
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer 04/29/10 Seattle
Dendreon Hires Roche Sales Boss 04/08/10 Seattle
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug 03/22/10 Seattle
Roche, Biogen Halt Arthritis Study 03/08/10 Boston
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.